Paresh C Gandhi
Examiner (ID: 305)
Most Active Art Unit | 2663 |
Art Unit(s) | 2663 |
Total Applications | 1 |
Issued Applications | 1 |
Pending Applications | 0 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18201238
[patent_doc_number] => 11583611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Biocompatible phase invertible proteinaceous compositions and methods for making and using the same
[patent_app_type] => utility
[patent_app_number] => 16/878061
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6696
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/878061 | Biocompatible phase invertible proteinaceous compositions and methods for making and using the same | May 18, 2020 | Issued |
Array
(
[id] => 17799017
[patent_doc_number] => 11413283
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Topical formulations for delivery of hedgehog inhibitor compounds and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/878301
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 23679
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878301
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/878301 | Topical formulations for delivery of hedgehog inhibitor compounds and use thereof | May 18, 2020 | Issued |
Array
(
[id] => 16282754
[patent_doc_number] => 20200276356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => LARGE 3D POROUS SCAFFOLDS MADE OF ACTIVE HYDROXYAPATITE OBTAINED BY BIOMORPHIC TRANSFORMATION OF NATURAL STRUCTURES AND PROCESS FOR OBTAINING THEM
[patent_app_type] => utility
[patent_app_number] => 16/875554
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875554
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/875554 | Large 3D porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them | May 14, 2020 | Issued |
Array
(
[id] => 16282753
[patent_doc_number] => 20200276355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => LARGE 3D POROUS SCAFFOLDS MADE OF ACTIVE HYDROXYAPATITE OBTAINED BY BIOMORPHIC TRANSFORMATION OF NATURAL STRUCTURES AND PROCESS FOR OBTAINING THEM
[patent_app_type] => utility
[patent_app_number] => 16/875543
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12366
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875543
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/875543 | Large 3D porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them | May 14, 2020 | Issued |
Array
(
[id] => 17539791
[patent_doc_number] => 11304894
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => Compositions, delivery devices, and methods thereof for feminine health
[patent_app_type] => utility
[patent_app_number] => 16/866454
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 8190
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866454
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/866454 | Compositions, delivery devices, and methods thereof for feminine health | May 3, 2020 | Issued |
Array
(
[id] => 16663866
[patent_doc_number] => 10933088
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Method of administration and treatment
[patent_app_type] => utility
[patent_app_number] => 16/866466
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 36355
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866466
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/866466 | Method of administration and treatment | May 3, 2020 | Issued |
Array
(
[id] => 16420681
[patent_doc_number] => 20200345879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => GRIP ASSISTING AND ANTI CONTAGION DEVICES
[patent_app_type] => utility
[patent_app_number] => 16/862955
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16862955
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/862955 | GRIP ASSISTING AND ANTI CONTAGION DEVICES | Apr 29, 2020 | Abandoned |
Array
(
[id] => 16569048
[patent_doc_number] => 20210008054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => USE OF CDK9 INHIBITORS TO REDUCE CARTILAGE DEGRADATION
[patent_app_type] => utility
[patent_app_number] => 16/863892
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863892
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/863892 | Use of CDK9 inhibitors to reduce cartilage degradation | Apr 29, 2020 | Issued |
Array
(
[id] => 17974331
[patent_doc_number] => 11491168
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Combination of Bcl-2/Bcl-xL inhibitors and chemotherapeutic agent and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/858758
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 67
[patent_no_of_words] => 18997
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858758
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/858758 | Combination of Bcl-2/Bcl-xL inhibitors and chemotherapeutic agent and use thereof | Apr 26, 2020 | Issued |
Array
(
[id] => 18716427
[patent_doc_number] => 11793748
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-24
[patent_title] => Pharmaceutical compositions of aspirin for parenteral administration
[patent_app_type] => utility
[patent_app_number] => 16/840095
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4489
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840095
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/840095 | Pharmaceutical compositions of aspirin for parenteral administration | Apr 2, 2020 | Issued |
Array
(
[id] => 17695929
[patent_doc_number] => 11369631
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-06-28
[patent_title] => Oral gelling liquid formulations
[patent_app_type] => utility
[patent_app_number] => 16/839385
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 8228
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16839385
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/839385 | Oral gelling liquid formulations | Apr 2, 2020 | Issued |
Array
(
[id] => 17602855
[patent_doc_number] => 11331324
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Modified release suspension of eslicarbazepine
[patent_app_type] => utility
[patent_app_number] => 16/828858
[patent_app_country] => US
[patent_app_date] => 2020-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7385
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16828858
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/828858 | Modified release suspension of eslicarbazepine | Mar 23, 2020 | Issued |
Array
(
[id] => 17593690
[patent_doc_number] => 20220143263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => THROMBIN-CARRYING HEMOSTATIC SHEET
[patent_app_type] => utility
[patent_app_number] => 17/440565
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17728
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440565
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/440565 | THROMBIN-CARRYING HEMOSTATIC SHEET | Mar 18, 2020 | Pending |
Array
(
[id] => 16326680
[patent_doc_number] => 20200297645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => FIBROUS WATER-SOLUBLE UNIT DOSE ARTICLES COMPRISING WATER-SOLUBLE FIBROUS STRUCTURES
[patent_app_type] => utility
[patent_app_number] => 16/823375
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823375
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823375 | Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures | Mar 18, 2020 | Issued |
Array
(
[id] => 17626203
[patent_doc_number] => 20220161218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => METHOD FOR COATING INSOLUBLE SOLIDS
[patent_app_type] => utility
[patent_app_number] => 17/440061
[patent_app_country] => US
[patent_app_date] => 2020-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440061
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/440061 | METHOD FOR COATING INSOLUBLE SOLIDS | Mar 16, 2020 | Pending |
Array
(
[id] => 16908001
[patent_doc_number] => 11040018
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-22
[patent_title] => Formulation for inhibiting formation of 5-HT2B agonists and methods of using same
[patent_app_type] => utility
[patent_app_number] => 16/811172
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 8945
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16811172
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/811172 | Formulation for inhibiting formation of 5-HT2B agonists and methods of using same | Mar 5, 2020 | Issued |
Array
(
[id] => 17155838
[patent_doc_number] => 20210316889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => METHOD FOR FILLING CONTAINERS WITH A POWDER
[patent_app_type] => utility
[patent_app_number] => 17/279549
[patent_app_country] => US
[patent_app_date] => 2020-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279549
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/279549 | Method for filling containers with a powder | Feb 25, 2020 | Issued |
Array
(
[id] => 18525082
[patent_doc_number] => 11712059
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-01
[patent_title] => Beaded tobacco material and related method of manufacture
[patent_app_type] => utility
[patent_app_number] => 16/798638
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18457
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798638
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/798638 | Beaded tobacco material and related method of manufacture | Feb 23, 2020 | Issued |
Array
(
[id] => 16267172
[patent_doc_number] => 20200268659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => NALOXONE FORMULATIONS FOR SUBLINGUAL AND/OR BUCCAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 16/797205
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16797205
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/797205 | Naloxone formulations for sublingual and/or buccal administration | Feb 20, 2020 | Issued |
Array
(
[id] => 16582735
[patent_doc_number] => 20210017137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/797776
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29629
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16797776
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/797776 | Salts of an epidermal growth factor receptor kinase inhibitor | Feb 20, 2020 | Issued |